It is time for ASTX to make new highs -- Just raised from hold to buy
In addition to a great pipeline of new potential drugs ASTX has been upgraded. Astex Pharmaceuticals Inc (ASTX) has been upgraded by TheStreet Ratings from hold to buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, compelling growth in net income, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company shows low profit margins.
The Street Rating does not even take into account the potential break through on pipeline drugs.
Yes, this upgrade can impact shorts. I am glad that I have been long for a long time when very few liked this stock.